410 related articles for article (PubMed ID: 19703825)
21. A community outbreak of Legionnaires' disease from an industrial cooling tower: assessment of clinical features and diagnostic procedures.
Hugosson A; Hjorth M; Bernander S; Claesson BE; Johansson A; Larsson H; Nolskog P; Pap J; Svensson N; Ulleryd P
Scand J Infect Dis; 2007; 39(3):217-24. PubMed ID: 17366051
[TBL] [Abstract][Full Text] [Related]
22. Community-acquired pneumonia and positive urinary antigen tests: Factors associated with targeted antibiotic therapy.
Mothes A; Léotard S; Nicolle I; Smets A; Chirio D; Rotomondo C; Tiger F; Del Giudice P; Perrin C; Néri D; Foucault C; Della Guardia M; Hyvernat H; Roger PM;
Med Mal Infect; 2016 Oct; 46(7):365-371. PubMed ID: 27377444
[TBL] [Abstract][Full Text] [Related]
23. Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.
File TM; Mandell LA; Tillotson G; Kostov K; Georgiev O
J Antimicrob Chemother; 2007 Jul; 60(1):112-20. PubMed ID: 17537866
[TBL] [Abstract][Full Text] [Related]
24. Urinary antigen testing in community-acquired pneumonia in adults: an update.
Viasus D; Calatayud L; McBrown MV; Ardanuy C; Carratalà J
Expert Rev Anti Infect Ther; 2019 Feb; 17(2):107-115. PubMed ID: 30618315
[TBL] [Abstract][Full Text] [Related]
25. [Contribution of urinary pneumococcal antigen detection combined with the research of legionella antigen for diagnosis of pneumonia in hospitalized patients].
Honoré S; Trillard M; Ould-Hocine Z; Lesprit P; Deforges L; Legrand P
Pathol Biol (Paris); 2004 Oct; 52(8):429-33. PubMed ID: 15465259
[TBL] [Abstract][Full Text] [Related]
26. Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.
Lui G; Ip M; Lee N; Rainer TH; Man SY; Cockram CS; Antonio GE; Ng MH; Chan MH; Chau SS; Mak P; Chan PK; Ahuja AT; Sung JJ; Hui DS
Respirology; 2009 Nov; 14(8):1098-105. PubMed ID: 19818051
[TBL] [Abstract][Full Text] [Related]
27. Evaluating the use of a Streptococcus pneumoniae urinary antigen detection kit for the management of community-acquired pneumonia in Japan.
Kobashi Y; Yoshida K; Miyashita N; Niki Y; Matsushima T
Respiration; 2007; 74(4):387-93. PubMed ID: 16582535
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain.
Gutiérrez F; Masiá M; Rodríguez JC; Ayelo A; Soldán B; Cebrián L; Mirete C; Royo G; Hidalgo AM
Clin Infect Dis; 2003 Feb; 36(3):286-92. PubMed ID: 12539069
[TBL] [Abstract][Full Text] [Related]
29. [Etiology of community-acquired pneumonia in ambulatory patients. Usefulness of a diagnostic investigation protocol using detection of Streptococcus pneumoniae and Legionella pneumophila antigens in urine samples].
Mirete Ferrer C; Gutiérrez Rodero F; Rodríguez Díaz JC; Royo García G; Shum Fhunk C; Martín Hidalgo A
Med Clin (Barc); 2001 Nov; 117(17):657-9. PubMed ID: 11734171
[TBL] [Abstract][Full Text] [Related]
30. Costs associated with shorter duration of antibiotic therapy in hospitalized patients with mild-to-moderate severe community-acquired pneumonia.
Opmeer BC; El Moussaoui R; Bossuyt PM; Speelman P; Prins JM; de Borgie CA
J Antimicrob Chemother; 2007 Nov; 60(5):1131-6. PubMed ID: 17827142
[TBL] [Abstract][Full Text] [Related]
31. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
32. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
[TBL] [Abstract][Full Text] [Related]
33. Legionnaires disease with bacteremic coinfection.
Tan MJ; Tan JS; File TM
Clin Infect Dis; 2002 Sep; 35(5):533-9. PubMed ID: 12173126
[TBL] [Abstract][Full Text] [Related]
34. [The epidemiology and clinical features of Legionella pneumonia (LP) in patients older than 60 years old who were hospitalized with pneumonia in northern Israel].
Ben-Dror G; Mizerizky Y; Viar G; Zuker M; Miron D
Harefuah; 2002 Aug; 141(8):680-2, 763. PubMed ID: 12222127
[TBL] [Abstract][Full Text] [Related]
35. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
Ioachimescu OC; Ioachimescu AG; Iannini PB
Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482
[TBL] [Abstract][Full Text] [Related]
36. Antibiotic strategy in severe community-acquired pneumococcal pneumonia.
Le Bris-Tomczak A; Bedos JP; Billon C; Samdjee F; Le Monnier A
Med Mal Infect; 2012 May; 42(5):226-34. PubMed ID: 22583782
[TBL] [Abstract][Full Text] [Related]
37. Use of serology and urine antigen detection to estimate the proportion of adult community-acquired pneumonia attributable to Streptococcus pneumoniae.
Watt JP; Moïsi JC; Donaldson RL; Reid R; Ferro S; Whitney CG; Santosham M; O'Brien KL
Epidemiol Infect; 2010 Dec; 138(12):1796-803. PubMed ID: 20334727
[TBL] [Abstract][Full Text] [Related]
38. β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial.
Garin N; Genné D; Carballo S; Chuard C; Eich G; Hugli O; Lamy O; Nendaz M; Petignat PA; Perneger T; Rutschmann O; Seravalli L; Harbarth S; Perrier A
JAMA Intern Med; 2014 Dec; 174(12):1894-901. PubMed ID: 25286173
[TBL] [Abstract][Full Text] [Related]
39. Legionella, Chlamydia pneumoniae and Mycoplasma infection in patients admitted to Christchurch Hospital with pneumonia.
Chambers ST; Town GI; Neill AM; Frampton C; Murdoch DR
N Z Med J; 1999 Jun; 112(1090):222-4. PubMed ID: 10448994
[TBL] [Abstract][Full Text] [Related]
40. [Diagnosis and ambulatory treatment of patients with community-acquired pneumonia: variability of complementary tests and study of the effectiveness of roxithromycin. Study Group on Ambulatory Treatment of Community-Acquired Pneumonia (NACTA)].
Rev Clin Esp; 1999 Nov; 199(11):700-4. PubMed ID: 10638232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
